Also in humans, constitutional increases in FGF3 and FGF4 have been associated with an increased risk of craniosynostosis [25], and FGF4 has been shown to be a negative prognostic indicator for a number of cancers due to its effect on tumor growth, angiogenesis, invasion and metastasis [26]. Here, FGF4 is linked to craniosynostosis.